Parecoxib reduces systemic inflammation and acute lung injury in burned animals with delayed fluid resuscitation

International Journal of Inflammation

Volumn 2014, Issue , 2014, Pages

  Chong, Si Jack ^a   Wong, Yong Chiat ^b   Wu, Jian ^b   Tan, Mui Hong ^b   Lu, Jia ^b   Moochhala, Shabbir M ^b  

^a Naval Medical Service   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; CYCLOOXYGENASE 2; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; HARTMANN SOLUTION; INTERLEUKIN 6; MYELOPEROXIDASE; PARECOXIB; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BURN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; FLUID RESUSCITATION; HISTOPATHOLOGY; INFLAMMATORY CELL; KIDNEY INJURY; MALE; MULTIPLE ORGAN FAILURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY DELAY; UREA NITROGEN BLOOD LEVEL;

EID: 84896697933     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2014/972645     Document Type: Article

References (46)

1. Demling R. H., The burn edema process: current concepts. Journal of Burn Care and Rehabilitation 2005 26 3 207 227 2-s2.0-19544387170 10.1097/01.BCR.0000162151.71482.B3 (Pubitemid 40733861)
2. Turnage R. H., Nwariaku F., Murphy J., Schulman C., Wright K., Yin H., Mechanisms of pulmonary microvascular dysfunction during severe burn injury. World Journal of Surgery 2002 26 7 848 853 2-s2.0-0036631896 10.1007/s00268-002-4063-3 (Pubitemid 36920328)
3. Dancey D. R., Hayes J., Gomez M., Schouten D., Fish J., Peters W., Slutsky A. S., Stewart T. E., ARDS in patients with thermal injury. Intensive Care Medicine 1999 25 11 1231 1236 2-s2.0-0032757633
4. Ipaktchi K., Mattar A., Niederbichler A. D., Kim J., Hoesel L. M., Hemmila M. R., Su G. L., Remick D. G., Wang S. C., Arbabi S., Attenuating burn wound inflammation improves pulmonary function and survival in a burn-pneumonia model. Critical Care Medicine 2007 35 9 2139 2144 2-s2.0-34548284474 10.1097/01.CCM.0000280568.61217.26 (Pubitemid 47326451)
5. Murphy T. J., Paterson H. M., Kriynovich S., Zang Y., Kurt-Jones E. A., Mannick J. A., Lederer J. A., Linking the "two-hit" response following injury to enhanced TLR4 reactivity. Journal of Leukocyte Biology 2005 77 1 16 23 2-s2.0-14644404948 10.1189/jlb.0704382 (Pubitemid 40310688)
6. He L.-K., Liu L. H., Hahn E., Gamelli R. L., The expression of cyclooxygenase and the production of prostaglandin E2 in neutrophils after burn injury and infection. Journal of Burn Care and Rehabilitation 2001 22 1 58 64 2-s2.0-0035138353
7. FitzGerald G. A., COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nature Reviews Drug Discovery 2003 2 11 879 890 2-s2.0-0242690224
8. Wilgus T. A., Ross M. S., Parrett M. L., Oberyszyn T. M., Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins and Other Lipid Mediators 2000 62 4 367 384 2-s2.0-0033791612 10.1016/S0090-6980(00)00089-7
9. Sio S. W. S., Ang S. F., Lu J., Moochhala S., Bhatia M., Substance p upregulates cyclooxygenase-2 and prostaglandin E metabolite by activating ERK1/2 and NF- B in a mouse model of burn-induced remote Acute lung injury. Journal of Immunology 2010 185 10 6265 6276 2-s2.0-78650664731 10.4049/jimmunol.1001739
10. Ozaki-Okayama Y., Matsumura K., Ibuki T., Ueda M., Yamazaki Y., Tanaka Y., Kobayashi S., Burn injury enhances brain prostaglandin E2 production through induction of cyclooxygenase-2 and microsomal prostaglandin E synthase in cerebral vascular endothelial cells in rats. Critical Care Medicine 2004 32 3 795 800 2-s2.0-1542614330 10.1097/01.CCM.0000114576.60077.FC (Pubitemid 38340079)
11. Kelsen J., Kjær K., Chen G., Pedersen M., Røhl L., Frøkiær J., Nielsen S., Nyengaard J. R., Rønn L. C. B., Parecoxib is neuroprotective in spontaneously hypertensive rats after transient middle cerebral artery occlusion: a divided treatment response? Journal of Neuroinflammation 2006 3, article 31 2-s2.0-33846679363 10.1186/1742-2094-3-31 (Pubitemid 46195487)
12. Walker H. L., Mason A. D. Jr., A standard animal burn. Journal of Trauma 1968 8 6 1049 1051 2-s2.0-0014356694
13. Aikawa N., Shinozawa Y., Ishibiki K., Clinical analysis of multiple organ failure in burned patients. Burns 1987 13 2 103 109 2-s2.0-0023215839 (Pubitemid 17062255)
14. Baskaran H., Yarmush M. L., Berthiaume F., Dynamics of tissue neutrophil sequestration after cutaneous burns in rats. Journal of Surgical Research 2000 93 1 88 96 2-s2.0-0033850282 10.1006/jsre.2000.5955
15. Singer A. J., Wang E., Taira B. R., Steinhauff N., Rooney J., Zimmerman T., Controlled mild hypothermia prolongs survival in a rat model of large scald burns. Academic Emergency Medicine 2011 18 3 287 291 2-s2.0-79952733312 10.1111/j.1553-2712.2011.01016.x
16. Zhang J.-P., Ying X., Liang W.-Y., Luo Z.-H., Yang Z.-C., Huang Y.-S., Wang W.-C., Apoptosis in cardiac myocytes during the early stage after severe burn. The Journal of Trauma 2008 65 2 401 408 2-s2.0-51649102624
17. Green R. M., Flamm S., AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002 123 4 1367 1384 2-s2.0-0036787433 10.1053/gast.2002.36061
18. Pratt D. S., Kaplan M. M., Evaluation of abnormal liver-enzyme results in asymptomatic patients. The New England Journal of Medicine 2000 342 17 1266 1271 2-s2.0-0034720287 10.1056/NEJM200004273421707 (Pubitemid 30235957)
19. Watkins P. B., Kaplowitz N., Slattery J. T., Colonese C. R., Colucci S. V., Stewart P. W., Harris S. C., Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. Journal of the American Medical Association 2006 296 1 87 93 2-s2.0-33745607004 10.1001/jama.296.1.87
20. Athyros V. G., Tziomalos K., Gossios T. D., Griva T., Anagnostis P., Kargiotis K., Pagourelias E. D., Theocharidou E., Karagiannis A., Mikhailidis D. P., Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. The Lancet 2010 376 9756 1916 1922 2-s2.0-78649890465 10.1016/S0140-6736(10)61272-X
21. Boelsterli U. A., Zimmerman H. J., Kretz-Rommel A., Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. Critical Reviews in Toxicology 1995 25 3 207 235 2-s2.0-0029050333
22. Bjorkman D., Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. The American Journal of Medicine 1998 105 5 17S 21S 2-s2.0-0032476571 10.1016/S0002-9343(98)00276-9 (Pubitemid 28553711)
23. Gauglitz G. G., Song J., Herndon D. N., Finnerty C. C., Boehning D., Barral J. M., Jeschke M. G., Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock 2008 30 5 503 507 2-s2.0-55949123388 10.1097/SHK.0b013e31816e3373
24. Chen L.-W., Hwang B., Chang W.-J., Wang J.-S., Chen J.-S., Hsu C.-M., Inducible nitric oxide synthase inhibitor reverses exacerbating effects of hypertonic saline on lung injury in burn. Shock 2004 22 5 472 477 2-s2.0-8144231055 10.1097/01.shk.0000140304.71215.f7 (Pubitemid 39472573)
25. Iseri S. Ö., Ersoy Y., Gedik N., Ercan F., Alican I., Protective role of adrenomedullin in burn-induced remote organ damage in the rat. Regulatory Peptides 2008 146 1-3 99 105 2-s2.0-38149113998 10.1016/j.regpep. 2007.08.023
26. Baxter C. R., Management of fluid volume and electrolyte changes in the early postburn period. Geriatrics 1975 30 11 57 62 2-s2.0-0016720824
27. Greenhalgh D. G., Warden G. D., The importance of intra-abdominal pressure measurements in burned children. Journal of Trauma 1994 36 5 685 690 2-s2.0-0028302320 (Pubitemid 24162095)
28. Latenser B. A., Kowal-Vern A., Kimball D., Chakrin A., Dujovny N., A pilot study comparing percutaneous decompression with decompressive laparotomy for acute Abdominal Compartment Syndrome in thermal injury. Journal of Burn Care and Rehabilitation 2002 23 3 190 195 2-s2.0-0036100032 (Pubitemid 34547759)
29. Hobson K. G., Young K. M., Ciraulo A., Palmieri T. L., Greenhalgh D. G., Release of abdominal compartment syndrome improves survival in patients with burn injury. Journal of Trauma: Injury, Infection and Critical Care 2002 53 6 1129 1133 2-s2.0-0036899305 (Pubitemid 35435106)
30. Oda J., Yamashita K., Inoue T., Harunari N., Ode Y., Mega K., Aoki Y., Noborio M., Ueyama M., Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns. Burns 2006 32 2 151 154 2-s2.0-32044439375 10.1016/j.burns.2005.08.011 (Pubitemid 43197649)
31. Finnerty C. C., Przkora R., Herndon D. N., Jeschke M. G., Cytokine expression profile over time in burned mice. Cytokine 2009 45 1 20 25 2-s2.0-57749092786 10.1016/j.cyto.2008.10.005
32. Kataranovski M., Magič Z., Pejnovič N., Early inflammatory cytokine and acute phase protein response under the stress of thermal injury in rats. Physiological Research 1999 48 6 473 482 2-s2.0-0033380379 (Pubitemid 30019557)
33. Gauglitz G. G., Song J., Herndon D. N., Finnerty C. C., Boehning D., Barral J. M., Jeschke M. G., Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock 2008 30 5 503 507 2-s2.0-55949123388 10.1097/SHK.0b013e31816e3373
34. Rodriguez J. L., Miller C. G., Garner W. L., Till G. O., Guerrero P., Moore N. P., Corridore M., Normolle D. P., Smith D. J., Remick D. G., Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. Journal of Trauma 1993 34 5 684 696 2-s2.0-0027208206 (Pubitemid 23171835)
35. Gehling M. H. G., Luesebrink T., Kulka P. J., Tryba M., The effective duration of analgesia after intrathecal morphine in patients without additional opioid analgesia: a randomized double-blind multicentre study on orthopaedic patients. European Journal of Anaesthesiology 2009 26 8 683 688 2-s2.0-70249107833 10.1097/EJA.0b013e328329b045
36. Luscombe K. S., McDonnell N. J., Muchatuta N. A., Paech M. J., Nathan E. A., A randomised comparison of parecoxib versus placebo for pain management following minor day stay gynaecological surgery. Anaesthesia and Intensive Care 2010 38 1 141 148 2-s2.0-75749130262
37. Lloyd R., Derry S., Moore R. A., McQuay H. J., Intravenous or intramuscular parecoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009 2 CD004771 2-s2.0-67549086982
38. Piper P., Vane J., The release of prostaglandins from lung and other tissues. Annals of the New York Academy of Sciences 1971 180 363 385 2-s2.0-0015245322
39. Whelton A., Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics. American Journal of Therapeutics 2000 7 2 63 74 2-s2.0-0034158368
40. Harris R. C., McKanna J. A., Akai Y., Jacobson H. R., Dubois R. N., Breyer M. D., Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. Journal of Clinical Investigation 1994 94 6 2504 2510 2-s2.0-0028034970 (Pubitemid 24379628)
41. Mori T., Cowley A. W. Jr., Ito S., Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. Journal of Pharmacological Sciences 2006 100 1 2 8 2-s2.0-31544451830 10.1254/jphs.FMJ05003X2 (Pubitemid 43161607)
42. Murray M. D., Brater D. C., Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annual Review of Pharmacology and Toxicology 1993 33 435 465 2-s2.0-0027478126 (Pubitemid 23116014)
43. Brater D. C., Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase -2-selective inhibition. American Journal of Medicine 1999 107 6 65S 70S 2-s2.0-0033428385
44. Arturson G., Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns 1996 22 4 255 274 2-s2.0-0029934690 10.1016/0305-4179(95)00153-0 (Pubitemid 26164129)
45. Bhatia M., Moochhala S., Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. Journal of Pathology 2004 202 2 145 156 2-s2.0-1142299409 10.1002/path.1491 (Pubitemid 38208651)
46. Dahiya P., Burns as a model of SIRS. Frontiers in Bioscience 2009 14 13 4962 4967 2-s2.0-69149101415 10.2741/3580